Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Clinical Medicine (London, England)|June 14, 2013
Frontline antibiotic therapyAlasdair MacGowan, Maha AlburCurrent Opinion in Pharmacology|August 25, 2011
Revisiting Beta-lactams - PK/PD improves dosing of old antibioticsAlasdair MacGowanInternational Journal of Antimicrobial Agents|April 30, 2002
Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro modelsAlasdair MacGowan, Karen BowkerThe Journal of Antimicrobial Chemotherapy|December 10, 2009
Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibilityDerek Brown, Alasdair MacgowanThe Journal of Antimicrobial Chemotherapy|July 4, 2006
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclinesKenneth N Agwuh, Alasdair MacGowanBreathe (Sheffield, England)|December 6, 2019
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapyAndrew W Creamer, Alice E Kent, Maha AlburAccess Microbiology|June 21, 2021
The value of MALDI-TOF failure to provide an identification of <i>Staphylococcal</i> species direct from blood cultures and rule out <i>Staphylococcus aureus</i> bacteraemia: a post-hoc analysis of the RAPIDO trialFergus Hamilton, Rebecca Evans, Alasdair MacGowanInternational Journal of Antimicrobial Agents|September 23, 2019
Comparative evaluation of eight in vitro pharmacodynamic models of infection: Activity of moxifloxacin against Escherichia coli and Streptococcus pneumoniae as an exemplary exampleAxel Dalhoff, Karen Bowker, Alasdair MacGowanThe Journal of Antimicrobial Chemotherapy|January 1, 2017
The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infectionAlasdair MacGowan, Sharon Tomaselli, Alan Noel, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Time to positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicentre randomized control trialFergus Hamilton, Rebecca Evans, Peter Ghazal, et al.Pageof 8